R1 HL Non-Rx FT

Based on the most helpful WSO content, Houlihan Lokey's non-RX groups, such as Corporate Finance (Corp Fin) and Financial Advisory Services (FAS), are generally considered less prestigious compared to their RX group. While the RX group is highly regarded for its deal flow and exit opportunities, the non-RX groups are often described as "mediocre at best" when compared to M&A groups at other firms.

For full-time recruiting in NYC, it's important to note that HL's RX and non-RX groups recruit separately. The RX group tends to have a more structured and competitive recruiting process, while non-RX recruiting may vary depending on the specific group and office. If you're targeting non-RX roles, it would be beneficial to network with professionals in those groups to understand their recruiting timelines and processes better.

Sources: Thoughts on Houlihan RX (NYC)? Exits, reputation, etc.?, Los Angeles IB SA Recruiting Mini-Guide, Recruiting for RX FT after M&A virtual internship?, Why You Should Consider Restructuring – Common Misconceptions/Insight on RX Groups, Guide to LA IB Scene (2023 Edition)